Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents

被引:18
|
作者
Kim, Jung-Sun [2 ]
Lee, Seung-Yul [2 ]
Lee, Jung Myung [2 ]
Yoon, Young Won [1 ]
Ahn, Chul-Min [2 ]
Kim, Myung-Hyun [1 ]
Min, Pil-Ki [1 ]
Ko, Young-Guk [2 ]
Hong, Bum-Kee [1 ]
Choi, Donghoon [2 ]
Kwon, Hyuck Moon [1 ]
Jang, Yangsoo [2 ]
Shim, Won-Heum [2 ]
机构
[1] Yonsei Univ, Coll Med, Yong Dong Severance Hosp, Div Cardiol, Seoul 135720, South Korea
[2] Yonsei Univ, Coll Med, Yong Dong Severance Hosp, Div Cardiol,Yonsei Cardiovasc Ctr, Seoul 135720, South Korea
关键词
restenosis; sirolimus-eluting stent; stent fracture; CLINICAL IMPACT; IMPLANTATION; PREDICTORS; LESIONS;
D O I
10.1097/MCA.0b013e32830fd101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Several reports have suggested that stent fractures in sirolimus-eluting stents (SESs) might be related to in-stent restenosis (ISR). However, the role of stent strut fracture in ISR has not been clearly elucidated. Therefore, we investigated the association of the SES fracture and ISR. Methods From 2003 to 2006, SES implantations with follow-up coronary angiography (CAG) for 628 lesions in 557 patients were analyzed. We reviewed clinical and procedural factors that might affect SES fracture and ISR. The median time interval from stent implantation to follow-up CAG was 9 months (range: 2-30 months). Results ISR occurred in 38 patients (5.7%), and 21 stent fractures (3.3%) were identified by follow-up CAG. Fourteen cases occurred in the left anterior descending artery, and seven occurred in the right coronary artery. The binary ISR rate in the stent fracture group was higher compared with that of the nonfracture group (38.1% vs. 4.6%, P < 0.001). Predictors of ISR as estimated by multivariate analysis were a stent diameter less than 2.75 mm [odds ratio (OR)=2.76, P=0.012], a stent length over 28 mm (OR=3.30, P=0.024), and stent fracture (OR=11.03, P < 0.001) after controlling for the angiographic and clinical risk factors of ISR. Conclusion Stent fracture was an independent predictor of ISR and may be one of the crucial mechanisms of ISR after implantation of an SES. Coron Artery Dis 20:59-63 (c) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 50 条
  • [21] Heterogeneous Neointimal Coverage Observed in the In-Stent Restenosis Occurred in Sirolimus-Eluting Stents
    Yano, Masamichi
    Awata, Masaki
    Nanto, Shinsuke
    Uematsu, Masaaki
    Morozumi, Takakazu
    Watanabe, Tetsuya
    Onishi, Toshinari
    Iida, Osamu
    Kawamoto, Kenji
    Sera, Fusako
    Minamiguchi, Hitoshi
    Ikeoka, Kuniyasu
    Okamoto, Shin
    Tanaka, Nobuaki
    Yasui, Haruyo
    Ishihara, Takayuki
    Dohi, Tomoharu
    Nagata, Seiki
    CIRCULATION, 2008, 118 (18) : S1050 - S1050
  • [22] Angiographic patterns of in-stent restenosis are different between sirolimus-eluting stents and paclitaxel-eluting Stents
    Hong, SJ
    Kim, MH
    Ahn, TH
    Bae, JH
    Ahn, YK
    Park, MY
    Shin, SH
    Shim, W
    Ro, YM
    Lim, DS
    CIRCULATION, 2005, 112 (17) : U537 - U537
  • [23] Angiographic patterns of in-stent restenosis are different between sirolimus-eluting stents and paclitaxel-eluting stents
    Hong, SJ
    Kim, MH
    Ahn, TH
    Bae, JH
    Ahn, YK
    Shim, WJ
    Ro, YM
    Lim, DS
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 168H - 169H
  • [24] Significant Association of Coronary Artery Calcification in Stent Delivery Route With Restenosis After Sirolimus-Eluting Stent Implantation
    Mori, Shumpei
    Yasuda, Satoshi
    Kataoka, Yu
    Morii, Isao
    Kawamura, Atsushi
    Miyazaki, Shunichi
    CIRCULATION JOURNAL, 2009, 73 (10) : 1856 - 1863
  • [25] Similar clinical outcomes for sirolimus-eluting stent implantation and coronary brachytherapy for the treatment of in-stent restenosis
    Saia, F
    Lemos, PA
    Hoye, A
    Sianos, G
    Arampatzis, CA
    van der Giessen, WJ
    Smits, PC
    van Domburg, RT
    de Feyter, PJ
    Serruys, PW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 90A - 90A
  • [26] Randomized study of sirolimus-eluting stent implantation versus coronary brachytherapy for diffuse in-stent restenosis
    Park, SJ
    Kim, YH
    Kim, MJ
    Ko, KH
    Park, KM
    Lee, CW
    Hong, MK
    Kim, JJ
    Lee, MM
    Koo, BK
    Park, SW
    CIRCULATION, 2004, 110 (17) : 564 - 564
  • [27] Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis
    Ota, Hideaki
    Mahmoudi, Michael
    Kitabata, Hironori
    Torguson, Rebecca
    Chen, Fang
    Satler, Lowell F.
    Suddath, William O.
    Pichard, Augusto D.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2015, 16 (02) : 84 - 89
  • [28] A stent fracture and restenosis of a sirolimus-eluting stent in the real world.
    Serikawa, T.
    Kawasaki, T.
    Tanaka, H.
    Koga, H.
    Shiraishi, R.
    Kamura, A.
    Orita, Y.
    Fukuyama, T.
    Koga, N.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08): : 6F - 6F
  • [29] Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis
    Fujii, K
    Mintz, GS
    Kobayashi, Y
    Carlier, SG
    Takebayashi, H
    Yasuda, T
    Moussa, I
    Dangas, G
    Mehran, R
    Lansky, AJ
    Reyes, A
    Kreps, E
    Collins, M
    Colombo, A
    Stone, GW
    Teirstein, PS
    Leon, MB
    Moses, JW
    CIRCULATION, 2004, 109 (09) : 1085 - 1088
  • [30] Characteristics of cases with coronary stent restenosis occurring in fractured sirolimus-eluting stents
    Amano, H.
    Wagatsuma, K.
    Yamazaki, J.
    EUROPEAN HEART JOURNAL, 2008, 29 : 589 - 589